Abstract
Shwachman-Diamond syndrome (SDS) is an autosomal recessive disorder characterised by exocrine pancreatic dysfunction, haematological and skeletal abnormalities. We have previously defined the SDS locus as a 2.7 cM interval spanning the centromere of chromosome 7. To facilitate additional analysis of this complex and poorly characterised region, a framework of ordered genetic markers at 7p11-q11, including six newly identified, has been constructed using somatic cell, radiation hybrid and STS-content mapping. We have identified shared disease haplotypes, that recur in unrelated families of common ethnic origin, and extend across the SDS locus. Detection of ancestral and intrafamilial recombination events in patients refined the SDS locus to a 1.9 cM interval at 7q11, which contains the tyrosylprotein sulfotransferase 1 (TPST1) gene. Patients with SDS were screened for mutations in TPST1 by sequencing of exons and intron–exon junctions. Two single nucleotide polymorphisms, but no disease-causing mutations, were identified. In addition, Southern blot analysis yielded no evidence of large-scale mutations, and RT–PCR analysis failed to detect alterations in expression. These results exclude TPST1 as the causative gene for SDS. The established map of the refined SDS locus will assist in the identification and characterisation of other candidate genes for SDS.
Similar content being viewed by others
Introduction
Shwachman-Diamond syndrome (SDS, MIM 260400) is a rare multi-organ disorder with estimated incidence of 1 : 77 000.1 It presents in infancy with failure to thrive and recurrent infections. The phenotypic spectrum can be broad and variable, but exocrine pancreatic dysfunction and haematological abnormalities are consistent features.2 Other common manifestations include short stature, skeletal abnormalities and liver dysfunction. Serious infections and acute myeloid leukaemia are primary concerns for morbidity and mortality in the syndrome. Segregation analysis in SDS has established autosomal recessive mode of inheritance,3 but the molecular defect remains unknown. Recently, a locus co-segregating with the disease on chromosome 7 was identified in a genome-wide scan, and recombination events defined a minimal 2.7 cM interval spanning the centromere.1 All the families analysed supported linkage to 7p12-q11, consistent with a single locus for SDS.
To further refine the disease locus, and facilitate positional cloning of the disease gene, a linkage disequilibrium mapping approach was taken. Transmission disequilibrium test (TDT) was used as a test of association in the presence of linkage,4 and haplotypes were constructed to identify founder chromosome(s) and ancestral recombination events. We constructed a physical map of the disease locus using somatic cell, radiation hybrid and STS-content mapping to establish the order of published and newly characterised markers used in genetic analysis, as well as to identify candidate genes for SDS.
As the best characterised gene mapped to the critical genetic interval, tyrosylprotein sulfotransferase 1 (TPST1) was selected for mutation analysis, given that both its function and expression pattern are consistent with multi-organ defects observed in SDS. It is widely expressed, and codes for a Golgi transmembrane protein involved in posttranslational modification of secreted and membrane-bound proteins.5 Involvement of TPST1 in the syndrome was assessed by exon sequencing, Southern blotting and expression analysis.
Materials and methods
Patients
Most of the families with SDS included in the study have been described elsewhere.1,2,6 Additional families were obtained through ongoing recruitment. Diagnosis of SDS was based on documented evidence of exocrine pancreatic and bone marrow dysfunction, with the latter most commonly involving chronic neutropenia.2 Consent was obtained from all participating families, and procedural approval was obtained from the human subjects review board of The Hospital for Sick Children (HSC). Genomic DNA was isolated from leukocytes or EBV transformed lymphoblasts.7
Genotyping and genomic library screening
Primer sequences were obtained from the Genome Database (http://gdbwww.gdb.org/) or designed using Primer3 software.8 Microsatellite marker alleles were amplified by PCR, resolved on a 6% sequencing gel, transferred to Hybond-N+ membrane and visualised by hybridisation to one of the PCR primers end-labelled with [α-32P] dCTP.9 SNP markers were typed by allele-specific PCR.9 New polymorphic markers derived from CEPH YAC 763g2 were identified by hybridisation of (CA)15 oligonucleotide to 800 YAC subclones,11 followed by sequencing.
Library screening of the chromosome 7-specific YAC library12 and the RPCI-11 BAC library13 was performed by PCR and oligonucleotide hybridisation, respectively.
Mutation analysis
DNA from anonymous unrelated individuals of Canadian origin was obtained from The Centre for Applied Genomics, HSC. Primers for amplification and sequencing were selected by the Primer3 software. Sequencing was performed using radiolabelled terminators (Amersham Pharmacia Biotech), and included at least 19 nucleotides of intron sequence at the intron-exon junctions. Sequence variants were characterised by bi-directional PCR amplification of specific alleles (Bi-PASA).14 For Southern blot analysis, genomic DNA was digested separately with HincII and BglI. The three probes used for hybridisation were amplified from genomic DNA or cDNA, and correspond to partial exon I (nucleotides 164–859 of TPST1 mRNA), complete exons II–IV (nucleotides 928–1223), and partial exon V (nucleotides 1282–1754). For RT–PCR analysis, total RNA was isolated from EBV transformed lymphoblasts,15 and reverse transcribed with SuperScriptTMII (Life Technologies) using random hexamers. The BLAST algorithm was used for database search and alignment.16
Results
Genetic analyses
The linkage disequilibrium study included 34 families of diverse ethnic origin from Canada, USA, Central and South America, Europe and Australia. Patients, parents and any unaffected siblings were genotyped at polymorphic marker loci extending across the SDS locus. Alleles at 19 marker loci (from D7S1485 to D7S482 in Figure 1, excluding RL15, RL14, B236I1 and D7S2503) were evaluated for association with disease using TDT. Transmissions from heterozygous parents to affected offspring of 34 parent–child trios were included in the test. After correction for multiple testing, none of the marker alleles showed significant excess transmission (positive association) or non-transmission (negative association) (data not shown).
Linkage disequlibrium, however, was detected by haplotype analysis. Haplotypes were constructed on disease chromosomes (chromosomes of affected individuals) and normal chromosomes (parental chromosomes not transmitted to affected offspring). Their comparison identified six haplotypes (I–VI in Figure 1), each of which occurred on two disease chromosomes of common ethnic origin and on none of the normal chromosomes. Notably, such extensive haplotype sharing was not detected among normal chromosomes. These observations suggest existence of multiple founder chromosomes in SDS.
To detect historical recombination events that may have occurred on these chromosomal backgrounds, haplotype analysis was extended to other available SDS families. Ancestral recombinants associated with disease haplotype II were observed in families SW93 and SW18, and those associated with haplotype IV were detected in family SW69 (Figure 1). The recombination events reduce the most likely location for the disease defect to an interval that is flanked by markers BS126 and D7S502, and is spanned by all six SDS haplotypes.
Refinement of the disease locus was supported and extended by observation of an intrafamilial recombination event in SDS family SW158, where the phase of the recombinant maternal chromosome was confirmed by genotyping first degree maternal relatives in an extended pedigree (Figure 2). The region of concordance between the affected and an unaffected sibling could be excluded from involvement in disease, thereby defining a new boundary for the SDS locus at marker D7S2429. Taken together, the ancestral and the intrafamilial recombinants position the SDS gene in the minimal 1.9 cM interval between D7S2429 and D7S502 (summarised in Figure 3).
Detection of the critical recombination events described above was facilitated by characterisation of six new polymorphic markers (Table 1), with at least six alleles observed for each marker in the SDS pedigrees. Markers BS126 and B236I1 were identified using the publicly available sequence of RPCI-11 BAC clones R-211B24 (TIGR: http://www.tigr.org/) and R-458F8 (GenBank17 at NCBI), respectively. Markers RL11, RL12, RL14 and RL15 were derived from CEPH YAC 763g2, selected for its large size and unambiguous localisation to 7q11.2 by fluorescence in situ hybridisation (YAC/BAC FISH Mapping Resource at MPIMG: http://www.mpimg-berlin-dahlem.mpg.de/∼cytogen/).
Physical mapping
In order to establish the relative order of published genetic markers, as well as those identified in this study, we used several complementary mapping methods. Initially, radiation hybrid mapping was performed, using the Stanford G3 panel.18 Several markers across the SDS locus (D7S499, D7S659, D7S2429, WIAF-183, D7S2549, D7S663, D7S502, D7S2503 and D7S482) had already been mapped at the Stanford Human Genome Center (SHGC),18 or by others (D7S1480).19 An additional 11 markers were typed twice on the panel, and data were submitted to the SHGC RH server for analysis. All markers were placed in high-confidence (1000:1) bins on the Stanford G3 RH map, v 2.018 (Figure 3) with lod scores greater than 7. Markers positioned in the same bin could not be ordered with high confidence, but were resolved by observation of intrafamilial recombination events (see Figure 1 legend), and by mapping on a YAC/BAC clone contig constructed across the 1.9 cM SDS locus.
The contig, shown in Figure 3, was established by STS-content mapping of YAC clones retrieved from CEPH and Washington University libraries based on information in published physical maps.20,21 In addition, the chromosome 7-specific YAC library and the RPCI-11 BAC library were screened for marker-positive clones. At later stages, physical mapping incorporated STSs developed from available BAC-end sequence (TIGR Database; Table 1), as well as EST-derived STSs predicted to map to the SDS locus on GeneMap'99.22
Based on integrated maps,21,23,24 it was evident that the 2.7 cM SDS locus spanned the centromere of chromosome 7. As the interval was saturated with genetic markers, the question arose as to which markers flank the centromere on the p and the q arms. This was of special interest in determining the chromosomal location of the critical recombination event in family SW158. To orient markers with respect to the alphoid domains of the centromere, two distinct chromosome 7-specific centromeric repeats,25 D7Z1 (Table 1) and D7Z2,26 were radiation hybrid mapped on the Stanford G3 panel and correlated with mapping results for the genetic markers (Figure 3). Chromosome arm assignment was directly confirmed by mapping markers and centromeric repeats on somatic cell hybrids RuRag 14-4-7-44 and RuRag 6-20-12 containing the short and the long arm of human chromosome 7, respectively27 (Figure 3). Together, the above findings position the refined 1.9 cM disease locus on the long arm of chromosome 7.
The refined SDS locus exceeds 1.9 Mb, the size predicted by the average 1 cM/Mb, based on radiation hybrid mapping and the constructed clone contig (see Discussion). The large physical size, as well as the pericentromeric location of the disease locus present difficulties for identification and characterisation of candidate genes. GeneMap'99 positions 28 transcripts within the critical genetic interval. To date, 13 ESTs and three known genes, TPST1, PMS2L4, and ZFD25, have been confirmed by us to map to the disease locus (Figure 3).
Mutation analysis of TPST1
In contrast to PMS2L4 and ZFD25, TPST1 is known to encode a functional protein product,5 and thus represents a true candidate gene for SDS. To facilitate mutation screening of TPST1, we established its genomic structure (Table 2). TPST1 mRNA sequence (AF038009) was aligned to the working draft sequence of the chromosome 7 BAC clone RP11-379F11 (AC026281), identified by BLASTN search of the HTGS database at NCBI. TPST1 consists of five exons, with consensus splice sites at the intron–exon boundaries. Coding sequence spans exons I–IV. Intron size was determined from contiguous genomic sequence available in GenBank for introns 1, 3 and 4 (AC079855, AC026281), and from that available in Celera Data (Celera Discovery System and Celera Genomics' associated databases) for intron 2 (hCG39437).
Each of the five TPST1 exons, including the intron–exon junctions, was amplified from genomic DNA and sequenced in five patients with SDS and one control individual. The patients are from five unrelated families used to establish linkage.1 Primers used are shown in Table 3. Two heterozygous sequence variants were identified, one in intron 2 (1126-19(G→A)), and another in the non-coding exon V (1599(T→G)). Each was observed in a single patient, and neither in the control sample. Using the Bi-PASA assay for detection of single nucleotide polymorphisms (Table 3), we confirmed that each of the two variants co-segregate with disease in the respective families. However, they were also found to occur in a control population of 52 individuals; the intron 2 variant was observed at frequency of 3%, and the exon V variant at 13%, indicating that they are not exclusively associated with SDS.
To exclude the possibility of local deletions and rearrangements not detected by sequencing, TPST1 cDNA probes were hybridised to genomic DNA of one control individual and four of the five patients described above. Observed band patterns for two different restriction enzymes were identical in control and patient samples, and as predicted by TPST1 sequence, suggesting that large-scale mutations in TPST1 are not the molecular defect in SDS.
We assessed TPST1 expression by RT–PCR (Table 3) in nine SDS patients, including those identified to carry intron 2 and exon V sequence variants. A single amplification product of expected size, corresponding to exons II–IV, was observed in all patient samples. Therefore, loss of TPST1 expression or mRNA instability can be excluded as causing disease.
Discussion
Using TDT for linkage disequilibrium mapping, we did not detect association of individual marker alleles with disease. This does not necessarily imply absence of linkage disequilibrium, but may reflect limited power of TDT due to small sample size and/or allelic heterogeneity at the disease locus. Given the relatively small number and the ethnic diversity of the family trios, haplotype analysis was a more powerful method to detect disequilibrium. Our observation of multiple founder chromosomes in SDS (Figure 1) is similar to findings in Wilson disease (MIM 277900). Also reminiscent of Wilson disease28,29 are haplotypes shared by patients of Italian and Northern European origin (II and IV in Figure 1).
To ensure that haplotype construction and interpretation of recombination events was correct, knowledge of marker order was essential. The resolution of genetic maps across the SDS locus is low.30,31 Furthermore, discrepancies were noted between genetic and physical maps.20,21 Survey of genomic sequence available in GenBank for this region revealed poor coverage with high degree of discontinuity, insufficient to resolve the inconsistencies. This is not surprising given the complex organisation of pericentromeric regions, including that of chromosome 7.32 The associated difficulties in mapping and sequence assembly33 emphasise the utility of our physical map for fine mapping studies, and underscore the value of the newly identified genetic markers.
The predicted size of the critical 1.9 cM interval, based on the Stanford G3 RH map, v 2.0, is 3.3 Mb, and yields 0.58 cM/Mb ratio of genetic and physical distance. This deviation from the average 1 cM/Mb appears to be due to reduced male recombination rate.31 Given the established correlation between the local recombination rate and the extent of linkage disequilibrium,34,35 the former may be directly related to extensive disease haplotype sharing, observed over large physical distances (based on 0.58 cM/Mb, 4.6 Mb for haplotypes V and VI, 7.3 Mb for haplotypes III and IV, and 16.5 Mb for haplotype I; Figure 1).
Since SDS is associated with a broad spectrum of clinical manifestations, it is difficult to predict the identity of the defective gene based on its functional features. Therefore, all genes in the critical genetic interval should be considered as candidates. Assessment of candidate genes is further complicated by the pericentromeric location of the refined SDS locus, where repetitive elements, including gene-related sequences, are abundant.32 This is well illustrated by the HSPC041gene.36 Based on sequence alignment, it is located on chromosome 8, with highly related pseudogenes found on chromosomes 7 (Figure 3), 15, and 17. Of the three known genes mapped to the SDS locus, two (PMS2L437 and ZFD2538; Figure 3) belong to gene families with multiple members mapped at 7q11, which is reminiscent of duplicated sequences associated with pericentromeric regions. In the absence of functional studies, it remains unclear whether these represent pseudogenes, or should be considered as candidate genes for SDS.
TPST1 is the best-characterised gene mapped to the SDS locus. Both publicly available22,39 and our own mapping data position TPST1 unambiguously within the SDS critical region (Figure 3), with no evidence of duplication locally or elsewhere in the genome. Broad tissue distribution of TPST1 mRNA (Northern blot analysis in Ouyang et al5) is consistent with multi-organ defects observed in SDS. This includes expression in the pancreas and liver,5 in neutrophils,40 and in the bone marrow (RT–PCR analysis by M Popovic, unpublished data), all of which are affected in SDS. Finally, functional implications of a defect in TPST1 are not inconsistent with the disease phenotype. Tyrosine sulfation of secreted and membrane-bound proteins is known to mediate protein–protein interactions involved in inflammatory and immune responses, such as leukocyte adhesion and chemokine signalling.41 This type of post-translational modification may be involved in signalling pathways that are of direct relevance to SDS. Although tyrosine sulfation has not been shown to be a dynamic process like phosphorylation, localisation of TPST1 and arylsulfatase E (ARSE) in the same subcellular compartment does support this possibility.42 Interestingly, mutations in ARSE gene lead to abnormalities in the skeletal system and short stature,42 which are components of the SDS phenotype.
Mutation analysis presented here excludes TPST1 as the candidate gene for SDS. Sequence analysis of exons and intron–exon junctions did not detect variants associated exclusively with disease. The identified sequence variants appear to co-segregate with SDS in affected families; however, they are positioned in the non-coding sequence, and also occur in controls. Recently, the same variants were observed in healthy Japanese individuals screened for single nucleotide polymorphisms.43 We also found no evidence for deletions or rearrangements. Finally, we observed TPST1 expression in patient lymphoblasts. Although mutations in regulatory elements, which may have more subtle effects on gene expression, remain a possibility, we conclude that TPST1 is not involved in SDS.
In summary, we have refined the SDS locus to a 1.9 cM interval at 7q11, supported by observation of shared disease haplotypes across this interval. Construction of a physical map of the disease locus, based on a framework of ordered genetic markers, has facilitated genetic analysis, as well as mapping of candidate genes in the critical genetic interval. One of these, TPST1, was excluded as the causative gene for SDS by mutation analysis. In the future, integration of our map with the increasingly available genomic sequence of the region will allow a more comprehensive characterisation of candidate genes for SDS. Ultimately, this work should lead to identification of disease-causing mutations, providing for a more accurate diagnosis and better understanding of this complex disorder.
References
Goobie S, Popovic M, Morrison J et al. Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7 Am J Hum Genet 2001 68: 1048–1054
Ginzberg H, Shin J, Ellis L et al. Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar J Pediatr 1999 135: 81–88
Ginzberg H, Shin J, Ellis L et al. Segregation analysis in Swachman-Diamond syndrome: evidence for recessive inheritance Am J Hum Genet 2000 66: 1413–1416
Spielman RS, McGinnis RE, Ewens WJ . Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM) Am J Hum Genet 1993 52: 506–516
Ouyang Y-B, Lane WS, Moore KL . Tyrosylprotein sulfotransferase: purification and molecular cloning of an enzyme that catalyzes tyrosine O-sulfation, a common posttranslational modification of eukaryotic proteins Proc Natl Acad Sci USA 1998 95: 2896–2901
Masuno M, Imaizumi K, Nishimura G et al. Shwachman syndrome associated with de novo reciprocal translocation t(6;12)(q16.2;q21.2) J Med Genet 1995 32: 894–895
Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988 16: 1215
Rozen S, Skaletsky HJ . Primer3. Code available at http://www-genome.wi.mit.edu/genome_software/other/primer3.html
Vignal A, Gyapay G, Hazan J et al. Nonradioactive multiplex procedure for genotyping of microsatellite markers in Adolph KW (ed) Methods in molecular genetics vol 1: Academic Press, San Diego 1993 pp 211–221
Little S . Amplification-refractory mutation system (ARMS) analysis of point mutations in Dracopoli NC, Haines JL, Korf BR et al. (eds) Current protocols in human genetics vol 2: John Wiley & Sons, New York 2000 pp 9.8.1–9.8.12
Hudson TJ . Colony hybridization to screen for microsatellites in Dracopoli NC, Haines JL, Korf BR et al. (eds) Current protocols in human genetics vol 1: John Wiley & Sons, New York 2000 pp 2.3.1–2.3.5
Scherer SW, Tompkins BJ, Tsui LC . A human chromosome 7-specific genomic DNA library in yeast artificial chromosomes Mamm Genome 1992 3: 179–181
Osoegawa K, Woon PY, Zhao B et al. An improved approach for construction of bacterial artificial chromosome libraries Genomics 1998 52: 1–8
Liu Q, Thorland EC, Heit JA, Sommer SS . Overlapping PCR for bidirectonal PCR amplification of specific alleles: a rapid one-tube method for simultaneously differentiating homozygotes and heterozygotes Genome Res 1997 7: 389–398
MacDonald RJ, Swift GH, Przybyla AE, Chirgwin JM . Isolation of RNA using guanidinium salts Methods Enzymol 1987 152: 219–227
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ . Basic local alignment search tool J Mol Biol 1990 215: 403–410
Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Rapp BA, Wheeler DL . GenBank Nucleic Acids Res 2000 28: 15–18
Stewart EA, McKusick KB, Aggarwal A et al. An STS-based radiation hybrid map of the human genome Genome Res 1997 7: 422–433
de la Puente A, Velasco E, Perez Jurado LA et al. Analysis of the monomeric alphoid sequences in the pericentromeric region of human chromosome 7 Cytogenet Cell Genet 1998 83: 176–181
Hudson TJ, Stein LD, Gerety SS et al. An STS-based map of the human genome Science 1995 270: 1945–1954
Bouffard GG, Idol JR, Braden VV et al. A physical map of human chromosome 7: an integrated YAC contig map with average STS spacing of 79 kb Genome Res 1997 7: 673–692
Deloukas P, Schuler GD, Gyapay G et al. A physical map of 30,000 human genes Science 1998 282: 744–746
Green ED, Idol JR, Mohr-Tidwell RM et al. Integration of physical, genetic and cytogenetic maps of human chromosome 7: isolation and analysis of yeast artificial chromosome clones for 117 mapped genetic markers Hum Mol Genet 1994 3: 489–501
Collins A, Frezal J, Teague J, Morton NE . A metric map of humans: 23,500 loci in 850 bands Proc Natl Acad Sci USA 1996 93: 14771–14775
Waye JS, England SB, Willard HF . Genomic organization of alpha satellite DNA on human chromosome 7: evidence for two distinct alphoid domains on a single chromosome Mol Cell Biol 1987 7: 349–356
Dunham I, Lengauer C, Cremer T, Featherstone T . Rapid generation of chromosome-specific alphoid DNA probes using the polymerase chain reaction Hum Genet 1992 88: 457–462
Vortkamp A, Thias U, Gessler M et al. A somatic cell hybrid panel and DNA probes for physical mapping of human chromosome 7p Genomics 1991 11: 737–743
Petrukhin K, Fischer SG, Pirastu M et al. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene Nat Genet 1993 5: 338–343
Figus A, Angius A, Loudianos G et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations Am J Hum Genet 1995 57: 1318–1324
Dib C, Faure S, Fizames C et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites Nature 1996 380: 152–154
Broman KW, Murray JC, Sheffield VC, White RL, Weber JL . Comprehensive human genetic maps: individual and sex-specific variation in recombination Am J Hum Genet 1998 63: 861–869
Horvath JE, Bailey JA, Locke DP, Eichler EE . Lessons from the human genome: transitions between euchromatin and heterochromatin Hum Mol Genet 2001 10: 2215–2223
Eichler EE . Segmental duplications: what's missing, misassigned, and misassembled - and should we care? Genome Res 2001 11: 653–656
Reich DE, Cargill M, Bolk S et al. Linkage disequilibrium in the human genome Nature 2001 411: 199–204
Yu A, Zhao C, Fan Y et al. Comparison of human genetic and sequence-based physical maps Nature 2001 409: 951–953
Zhang Q-H, Ye M, Wu X-Y et al. Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells Genome Res 2000 10: 1546–1560
Horii A, Han H-J, Sasaki S, Shimada M, Nakamura Y . Cloning, characterization and chromosomal assignment of the human genes homologous to yeast PMS1, a member of mismatch repair genes Biochem Biophys Res Commun 1994 204: 1257–1264
Li X-A, Kokame K, Okubo K et al. Cloning and characterization of a novel human gene encoding a zinc finger protein with 25 fingers Biochim Biophys Acta 1999 1489: 405–412
Olivier M, Aggarwal A, Allen J et al. A high-resolution radiation hybrid map of the human genome draft sequence Science 2001 291: 1298–1302
Tu L, Murphy PG, Li X, Tedder TF . L-selectin ligands expressed by human leukocytes are HECA-452 antibody-defined carbohydrate epitopes preferentially displayed by P-selectin glycoprotein ligand-1 J Immunol 1999 163: 5070–5078
Kehoe JW, Bertozzi CR . Tyrosine sulfation: a modulator of extracellular protein-protein interactions Chem Biol 2000 7: R57–R61
Daniele A, Parenti G, d'Addio M, Andria G, Ballabio A, Meroni G . Biochemical characterization of arylsulfatase E and functional analysis of mutations found in patients with X-linked chondrodysplasia punctata Am J Hum Genet 1998 62: 562–572
Iida A, Sekine A, Saito S et al. Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes J Hum Genet 2001 46: 225–240
Wang DG, Fan JB, Siao CJ et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome Science 1998 280: 1077–1082
Kunz J, Scherer SW, Klawitz I et al. Regional localization of 725 human chromosome 7-specific yeast artificial chromosome clones Genomics 1994 22: 439–448
Acknowledgements
We are grateful for the co-operation of the patients with SDS, their families, and their physicians. We thank the Canadian Institutes of Health Research (CIHR) Genome Resource Facility at HSC for YAC and BAC library screening. We also acknowledge support from Shwachman-Diamond Canada, Shwachman Support of Great Britain, The Harrison Wright Appeal, Shwachman-Diamond Support of Australia, Shwachman-Diamond Support International, and the CIHR. JM Rommens is a member of the Canadian Genetic Diseases Network (CGDN). M Popovic received a joint CGDN-HSC Award and an Ontario Graduate Scholarship. S Goobie received a Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Popovic, M., Goobie, S., Morrison, J. et al. Fine mapping of the locus for Shwachman-Diamond syndrome at 7q11, identification of shared disease haplotypes, and exclusion of TPST1 as a candidate gene. Eur J Hum Genet 10, 250–258 (2002). https://doi.org/10.1038/sj.ejhg.5200798
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejhg.5200798
Keywords
This article is cited by
-
Diagnostic workup of patients with pancreatic diseases
European Surgery (2009)
-
Mutations in SBDS are associated with Shwachman–Diamond syndrome
Nature Genetics (2003)